microdosing semaglutide for weight loss One Size Does Not Fit All: Understanding Diabetes in Multidose Pens I Microdosed Semaglutide at 0.1

Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)

This newer weight-loss medication was first developed to treat diabetes

This minimizes the risk of introducing bacteria under the skin

Many Patients Who Stop Weight Loss Drug Keep Pounds Off Recent studies have shown a connection between weight gain and the cessation of medication intake